Follow the Kairos Pharma, LTD. share price and the full management transaction log of the company, a listed equity based in United States. Shares are listed on the US market, under the supervision of SEC (Form 4). Market capitalisation: €8.3m. The latest transaction was filed on 30 December 2025 (Attribution). Among the most active insiders: Murali Ramachandran. All data is free.
14
Insider Decl.
n/a
Thresholds
€9,315
3 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Kairos Pharma, LTD. Strong Buy (bullish), based on 2 analysts. Average price target: US$7.00.
49Σ signal
Buys €9,315n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.